Tech Moves: Adaptive Biotechnologies’ chief medical officer resigns; Athira Pharma’s new hires

ByLois V. Aguirre

Mar 26, 2022 #Absorbable Modified Polymers Technology, #Advanced Technology Grants Pass, #Aidan'S Professional Technology Services, #Albuquerque Nm Information Technology Recruiters, #Bhd Technology Vr, #Catholic "Information Technology, #Ceo Comcast Technology, #Computer Technology Electronic, #Current Applications Of Rdna Technology, #Disadvantages Technology Law, #Ferrum Technology Services, #Fundamentals Of Medical Laboratory Technology, #Gmu Department Of Information Technology, #Hornborg Alf Technology Effects, #I'M Done Working In Technology, #James V. Arms Technology, #Jurassic Park Technology Analysis, #Liquidmetal Technology News, #Llc, #Mathey Technology And Engineering, #Medical Technology In 500 Bc, #Musc Library Technology Downloads, #New Jersey Technology Office Space, #Pc Ralley Technology, #Ridge Technology Services, #Technology 3x Reverse Etf, #Technology Abuse Use, #Technology Adoption Three Types, #Technology Advantage Info, #Technology And Improving Menial Jobs, #Technology Classroom Building 311, #Technology Companys In Usa, #Technology Distracting Studying Students, #Technology Docking Stations, #Technology Enablement White Paper, #Technology Images For Ppt, #Technology Impact On Finance Departments, #Technology In Chennai, #Technology In Greek Translation, #Technology Into History Lesson, #Technology Is Electricity Ted Talks, #Technology Professionals Of British Columbia, #Technology Relatesecuirty Topics, #Technology Studies Emu, #Technology To Prevent Medication Errors, #Technology Want What Ails Look, #Tesla Technology Roadmap, #Veterinary Assisting Vs Veterinary Technology, #Wentworth Institute Of Technology Animation, #What Is Today'S Technology, #With The Arise Of Technology

[ad_1]

Lance Baldo. (Adaptive Photo)

Lance Baldo stepped down as chief medical officer of Adaptive Biotechnologies. Baldo is “moving on to pursue another professional opportunity in the early cancer screening market close to home,” a spokesperson for the Seattle company told GeekWire. The physician and former head of U.S. medical affairs at Genentech has been based out of South San Francisco and joined publicly traded Adaptive in 2019.

The move comes after Adaptive laid off 12% of its workforce, about 100 employees, in early March. The company also announced a new CFO, Tycho Peterson, and narrowed its focus to two key business areas, immune medicine and detection of minimal residual disease (MRD) in oncology.

The medical team now reports to Sharon Benzeno, chief commercial officer for immune medicine, and Nitin Sood, chief commercial officer for MRD. Benzeno was previously a company-wide chief business development officer and Sood was chief commercial officer.

Adaptive’s partnership with South San Francisco-based Genentech to develop T-cell based cellular therapies will continue.

— Athira Pharma announced new hires and promotions. Josh Pan was promoted to VP of corporate development and Robert Renninger to VP of finance and accounting. The company hired Simon Daggett as VP of clinical operations; he was previously head of clinical operation at Bioniz Therapeutics and was director of clinical development at Allergan. The company also hired Lana Gloukhova as VP of drug safety and pharmacovigilance.

Athira has been regrouping after the departure of its long-time CEO and co-founder Leen Kawas this fall, in the wake of a company investigation into data integrity of scientific papers she co-authored. The company expects to announce top-line data next quarter on a phase 2 clinical trial of its experimental therapy for Alzheimer’s disease and has other ongoing trials.



[ad_2]

Source link